Immunotherapy Applications (Telomerase and HER2) with Gene Electrotransfer

[1]  E. de Azambuja,et al.  HER2-positive advanced breast cancer treatment in 2020. , 2020, Cancer treatment reviews.

[2]  G. Ciliberto,et al.  Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study , 2020, Journal of Translational Medicine.

[3]  G. Vandermeulen,et al.  Cancer DNA vaccines: current preclinical and clinical developments and future perspectives , 2019, Journal of Experimental & Clinical Cancer Research.

[4]  G. Ciliberto,et al.  Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma , 2018, Journal of Translational Medicine.

[5]  G. Lubas,et al.  Overexpression of HER-2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma - A marker of malignancy and possible therapeutic target. , 2018, Veterinary and comparative oncology.

[6]  L. Aurisicchio,et al.  Electroporation in veterinary oncology. , 2016, Veterinary journal.

[7]  F. Adega,et al.  Cat Mammary Tumors: Genetic Models for the Human Counterpart , 2016, Veterinary sciences.

[8]  Laure Lambricht,et al.  Clinical potential of electroporation for gene therapy and DNA vaccine delivery , 2016, Expert opinion on drug delivery.

[9]  Damijan Miklavčič,et al.  Electroporation-based applications in biotechnology. , 2015, Trends in biotechnology.

[10]  L. Heller,et al.  Gene electrotransfer clinical trials. , 2015, Advances in genetics.

[11]  F. Cavallo,et al.  The importance of comparative oncology in translational medicine , 2015, Cancer Immunology, Immunotherapy.

[12]  G. Ciliberto,et al.  Electro-gene-transfer as a new tool for cancer immunotherapy in animals. , 2014, Veterinary and comparative oncology.

[13]  R. Pierce,et al.  Systemic antitumor effect and clinical response in a phase 2 trial of intratumoral electroporation of plasmid interleukin-12 in patients with advanced melanoma. , 2014 .

[14]  G. Ciliberto,et al.  Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models. , 2014, Human gene therapy.

[15]  S. Vasan.  Electroporation-mediated administration of candidate DNA vaccines against HIV-1. , 2014, Methods in molecular biology.

[16]  Julie Gehl,et al.  Gene electrotransfer in clinical trials. , 2014, Methods in molecular biology.

[17]  R. Mancini,et al.  Cancer vaccination by electro-gene-transfer , 2013, Expert review of vaccines.

[18]  J. Hauptman,et al.  A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma. , 2013, Veterinary and comparative oncology.

[19]  G. Ciliberto,et al.  Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma. , 2013, Human gene therapy.

[20]  N. Sardesai,et al.  Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses , 2012, Science Translational Medicine.

[21]  G. Ciliberto,et al.  Genetic cancer vaccines: current status and perspectives , 2012, Expert opinion on biological therapy.

[22]  H. Takamatsu,et al.  A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease. , 2012, Antiviral research.

[23]  Wen-Ying Yu,et al.  Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model. , 2011, Vaccine.

[24]  F. Ansaldi,et al.  Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement , 2011, Expert opinion on biological therapy.

[25]  G. Ciliberto,et al.  A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  Richard Heller,et al.  Electroporation gene therapy preclinical and clinical trials for melanoma. , 2010, Current gene therapy.

[27]  Julie Gehl,et al.  Gene electrotransfer to skin; review of existing literature and clinical perspectives. , 2010, Current gene therapy.

[28]  G. Ciliberto,et al.  A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine. , 2010, Vaccine.

[29]  G. Ciliberto,et al.  Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs. , 2010, Vaccine.

[30]  G. Ciliberto,et al.  Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  I. Ramshaw,et al.  Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunity , 2009, Expert review of vaccines.

[32]  Shulin Li,et al.  Electroporation advances in large animals. , 2009, Current gene therapy.

[33]  G. Pelled,et al.  Ultrasound-based nonviral gene delivery induces bone formation in vivo , 2008, Gene Therapy.

[34]  S. Domchek,et al.  Differential lysis of tumors by polyclonal T cell lines and T cell clones specific for hTERT , 2007, Cancer biology & therapy.

[35]  M. Moasser.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis , 2007, Oncogene.

[36]  P. Monaci,et al.  Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates , 2007, International journal of cancer.

[37]  A. Folgori,et al.  Modulation of the Immune Response Induced by Gene Electrotransfer of a Hepatitis C Virus DNA Vaccine in Nonhuman Primates , 2006, The Journal of Immunology.

[38]  Damijan Miklavčič,et al.  Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study , 2006 .

[39]  J. Wolchok,et al.  Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. , 2006, Vaccine.

[40]  Y. Glinka,et al.  Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. , 2006, Current gene therapy.

[41]  G. Ciliberto,et al.  DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection. , 2005, Human gene therapy.

[42]  Donna Niedzwiecki,et al.  Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer 1 , 2005, The Journal of Immunology.

[43]  P. Parren,et al.  Therapeutic antibody gene transfer: an active approach to passive immunity. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  D. Scherman,et al.  Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants. , 2004, Human gene therapy.

[45]  L. Babiuk,et al.  Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. , 2004, Journal of biotechnology.

[46]  G. Ciliberto,et al.  Gene electro‐transfer improves transduction by modifying the fate of intramuscular DNA , 2003, The journal of gene medicine.

[47]  D. Wells,et al.  High-efficiency plasmid gene transfer into dystrophic muscle , 2003, Gene Therapy.

[48]  A. E. Trezíse.  In vivo DNA electrotransfer. , 2002, DNA and cell biology.

[49]  H. Yamanaka,et al.  In Vivo Gene Transfer of Hepatocyte Growth Factor to Skeletal Muscle Prevents Changes in Rat Kidneys After 5/6 Nephrectomy , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[50]  J. Miyazaki,et al.  Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditis , 2002, Gene Therapy.

[51]  D. Dean,et al.  High‐level gene transfer to the cornea using electroporation , 2002, The journal of gene medicine.

[52]  F Hoover,et al.  A double-injection DNA electroporation protocol to enhance in vivo gene delivery in skeletal muscle. , 2000, Analytical biochemistry.

[53]  C B Harley,et al.  Telomerase catalytic subunit homologs from fission yeast and human. , 1997, Science.

[54]  T. Muramatsu,et al.  Foreign gene expression in the mouse testis by localized in vivo gene transfer. , 1997, Biochemical and biophysical research communications.

[55]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.